Letter to the Editor : Selpercatinib-Enhanced Radioiodine Uptake in RET-Rearranged Thyroid Cancer
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:31 |
|---|---|
| Enthalten in: |
Thyroid : official journal of the American Thyroid Association - 31(2021), 10 vom: 15. Okt., Seite 1603-1604 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Groussin, Lionel [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 25.03.2022 Date Revised 25.03.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1089/thy.2021.0144 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM329492772 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM329492772 | ||
| 003 | DE-627 | ||
| 005 | 20231225205233.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1089/thy.2021.0144 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1098.xml |
| 035 | |a (DE-627)NLM329492772 | ||
| 035 | |a (NLM)34405703 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Groussin, Lionel |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Letter to the Editor |b Selpercatinib-Enhanced Radioiodine Uptake in RET-Rearranged Thyroid Cancer |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 25.03.2022 | ||
| 500 | |a Date Revised 25.03.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Iodine Radioisotopes |2 NLM | |
| 650 | 7 | |a NCOA4 protein, human |2 NLM | |
| 650 | 7 | |a Nuclear Receptor Coactivators |2 NLM | |
| 650 | 7 | |a Oncogene Proteins, Fusion |2 NLM | |
| 650 | 7 | |a Pyrazoles |2 NLM | |
| 650 | 7 | |a Pyridines |2 NLM | |
| 650 | 7 | |a Radiopharmaceuticals |2 NLM | |
| 650 | 7 | |a selpercatinib |2 NLM | |
| 650 | 7 | |a CEGM9YBNGD |2 NLM | |
| 650 | 7 | |a Proto-Oncogene Proteins c-ret |2 NLM | |
| 650 | 7 | |a EC 2.7.10.1 |2 NLM | |
| 650 | 7 | |a RET protein, human |2 NLM | |
| 650 | 7 | |a EC 2.7.10.1 |2 NLM | |
| 700 | 1 | |a Bessiene, Laura |e verfasserin |4 aut | |
| 700 | 1 | |a Arrondeau, Jennifer |e verfasserin |4 aut | |
| 700 | 1 | |a Garinet, Simon |e verfasserin |4 aut | |
| 700 | 1 | |a Cochand-Priollet, Béatrix |e verfasserin |4 aut | |
| 700 | 1 | |a Lupo, Audrey |e verfasserin |4 aut | |
| 700 | 1 | |a Zerbit, Jérémie |e verfasserin |4 aut | |
| 700 | 1 | |a Clerc, Jérôme |e verfasserin |4 aut | |
| 700 | 1 | |a Huillard, Olivier |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Thyroid : official journal of the American Thyroid Association |d 1990 |g 31(2021), 10 vom: 15. Okt., Seite 1603-1604 |w (DE-627)NLM013075799 |x 1557-9077 |7 nnns |
| 773 | 1 | 8 | |g volume:31 |g year:2021 |g number:10 |g day:15 |g month:10 |g pages:1603-1604 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1089/thy.2021.0144 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 31 |j 2021 |e 10 |b 15 |c 10 |h 1603-1604 | ||